Summary
Permeabilized L5178Y cells were used to investigate the mechanism underlying inhibition of the repair of irradiation-induced DNA strand breaks by 2′-deoxyeoformycin combined with deoxyadenosine. Permeabilized cells repaired DNA strand breaks as effectively as did intact cells, and at deoxyadenosine concentrations that produced similar levels of deoxyadenosine triphosphate (dATP), repair of DNA strand breaks was inhibited by 2′-deoxycoformycin plus deoxyadenosine to a comparable extent in both types of cells. Accompanying the increase in intracellular dATP produced by 2′-deoxycoformycin combined with deoxyadenosine was a fall in levels of deoxythymidine triphosphate (dTTP), deoxyguanosine triphosphate (dGTP), and deoxycytidine triphosphate (dCTP). The addition of dTTP, dGTP, and dCTP reversed the inhibition of DNA repair by 2′-deoxycoformycin plus deoxyadenosine, although the level of dATP was not affected. Reducing the phosphorylation of deoxy-adenosine to dATP by the addition of adenosine prevented the decrease in levels of dTTP, dGTP, and dCTP and the inhibition of DNA repair by 2′-deoxycoformycin and deoxyadenosine. In contrast, increasing the intracellular levels of dATP by the addition of 2′-deoxycoformycin together with dATP, deoxyadenosine diphosphate (dADP), or deoxyadenosine monophosphate (dAMP) had no effect on the levels of the other deoxynucleotide triphosphates and did not inhibit DNA repair. Moreover, DNA repair was not inhibited by the breakdown products of deoxyadenosine, adenine, or deoxyribose. These results suggest that inhibition of the repair of irradiation-induced DNA strand breaks by 2′-deoxycoformycin combined with deoxyadenosine requires the phosphorylation of deoxyadenosine and involves alterations in the levels of deoxynucleotide triphosphates.
Similar content being viewed by others
References
Bagnara AS, Hershfield MS (1982) Mechanism of deoxyadenosine-induced catabolism of adenosine ribonucleotides in adenosine deaminase-inhibited human T-lymphoblastoid cells. Proc Natl Acad Sci USA 79:2673
Begleiter A, Grover J, Froese E, Goldenberg GJ (1983) Membrane transport, sulfhydryl levels and DNA crosslinking in Chinese hamster ovary cell mutants sensitive and resistant to melphalan. Biochem Pharmacol 32:293
Begleiter A, Pugh L, Israels LG, Johnston JB (1988) Enhanced cytotoxicity and inhibition of DNA damage repair in irradiated murine L5178Y lymphoblasts and human chronic lymphocytic leukemia cells treated with 2′-deoxycoformycin and deoxyadenosine in vitro. Cancer Res 48:3981
Berger NA, Johnson ES (1976) DNA synthesis in permeabilized mouse L cells. Biochim Biophys Acta 425:1
Brox L, Ng A, Pollock E, Belch A (1984) DNA strand breaks induced in human T-lymphocytes by the combination of deoxyadenosine and deoxycoformycin. Cancer Res 44:934
Cohen A, Thompson E (1986) DNA repair in nondividing human lymphocytes: inhibition by deoxyadenosine. Cancer Res 46:1585
Dresler SL, Roberts JD, Lieberman WW (1982) Characterization of deoxyribonucleic acid repair synthesis in permeable human fibroblasts. Biochemistry 21:2557
Grever MR, Siaw MFE, Jacob WF, Neidhart JA, Miser JS, Coleman MS, Hutton JJ, Balcerzak SP (1981) The biochemical and clinical consequences of 2′-deoxycoformycin in refractory lymphoproliferative malignancy. Blood 57:406
Grever MR, Leiby JM, Kraut EH, Wilson HE, Neidhart JA, Wall RL, Balcerzak SP (1985) Low-dose deoxycoformycin in lymphoid malignancy. J Clin Oncol 3:1196
Hunting D, Henderson JF (1981) Determination of deoxyribonucleoside triphosphates using DNA polymerase: a critical evaluation. Can J Biochem 59:723
Johnston JB, Glazer RI, Pugh L, Israels LG (1986) The treatment of hairy-cell leukemia with 2′-deoxycoformycin. Br J Haematol 63:525
Kraut EH, Bouroncle BA, Grever MR (1986) Low-dose deoxycoformycin in the treatment of hairy-cell leukemia. Blood 68:1119
Matsumoto SS, Yu J, Yu AL (1983) Inhibition of RNA synthesis by deoxyadenosine plus deoxycoformycin in resting lymphocytes. J Immunol 131:2762
Matsumoto SS, Yu J, Yu AL (1988) The effect of deoxyadenosine plus deoxycoformycin on replicative and repair synthesis of DNA in human lymphoblasts and isolated nuclei. J Biol Chem 263:7153
Nguyen BT, Sadee W (1986) Compartmentation of guanine nucleotide precursors for DNA synthesis. Biochem J 234:263
O'Dwyer PJ, Wagner B, Leyland-Jones B, Wittes RE, Cheson BD, Hoth DF (1988) 2′-Deoxycoformycin (Pentostatin) for lymphoid malignancies. Ann Intern Med 108:733
Reichard P (1988) Interactions between deoxyribonucleotide and DNA synthesis. Annu Rev Biochem 57:349
Seto S, Carrera CJ, Kubata M, Wasson DB, Carson DA (1985) Mechanism of deoxyadenosine and 2′-chlorodeoxyadenosine toxicity in non-dividing human lymphocytes. Clin Invest 75:377
Seto S, Carrera CJ, Wasson DB, Carson DA (1986) Inhibition of DNA repair by deoxyadenosine in resting human lymphocytes. J Immunol 136:2839
Siaw MFE, Mitchell BS, Koller CA, Coleman MS, Hutton JJ (1980) ATP depletion as a consequence of adenosine deaminase inhibition in men. Proc Natl Acad Sci USA 77:6157
Spiers AS, Moore D, Cassileth PA, Harrington DP, Cummings FJ, Neiman RS, Bennett JM, O'Connell MJ (1987) Remissions in hairy-cell leukemia with pentostatin (2′-deoxycoformycin). N Engl J Med 316:825
Ullman B, Clift SM, Gudas LJ, Levinson BB, Wormsted MA, Martin DW (1980) Alterations in deoxyribonucleotide metabolism in cultured cells with ribonucleotide reductase activities refractory to feedback inhibition by 2′-deoxyadenosine triphosphate. J Biol Chem 255:8308
Zunica G, Marini M, Brunelli MA, Chiricolo M, Franceschi C (1986)d-Ribose inhibits DNA repair synthesis in human lymphocytes. Biochem Biophys Res Commun 138:673
Author information
Authors and Affiliations
Additional information
This study was supported by grants from the Medical Research Council of Canada, Parke-Davis Canada, Inc., and the National Cancer Institute of Canada.
Rights and permissions
About this article
Cite this article
Begleiter, A., Verburg, L., Israels, L.G. et al. Factors influencing the inhibition of repair of irradiation-induced DNA damage by 2′-deoxycoformycin and deoxyadenosine. Cancer Chemother. Pharmacol. 30, 65–69 (1992). https://doi.org/10.1007/BF00686487
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00686487